SCHEMBL19476289

SCHEMBL19476289

CCNCc1ccc(=O)[nH]c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.39
ALDH1A1 P00352 2/20 0.38
TRPV6 Q9H1D0 1/20 0.37
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
IDH1 O75874 1/20 0.34
MET P08581 1/20 0.34
SYK P43405 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MLLT1 Q03111 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
NEK1 Q96PY6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954179 0.85 PARP1 (0.45) PARP1ALDH1A1TRPV6LMNASMN1; SMN2
SCHEMBL178440 0.80 LOXL2 (0.41) PARP1ALDH1A1TRPV6LMNAGAA
SCHEMBL12844536 0.78 GPR84 (0.42) ALDH1A1TRPV6LMNAMEN1KMT2A
SCHEMBL313756 0.77
SCHEMBL20988117 0.77 KDM4E (0.40) PARP1ALDH1A1TRPV6LMNAGAA
SCHEMBL4827198 0.76 ALDH1A1 (0.40) ALDH1A1TRPV6LMNAGAASMN1; SMN2
SCHEMBL19090766 0.75 CYP2D6 (0.41) PARP1ALDH1A1TRPV6LMNAGAA
SCHEMBL15934339 0.75 LMNA (0.41) ALDH1A1LMNAGAASMN1; SMN2MEN1
SCHEMBL19954180 0.75 TRPV6 (0.39) ALDH1A1TRPV6LMNAGAASMN1; SMN2
SCHEMBL1196047 0.74 KMT2A (0.51) ALDH1A1LMNAGAASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017181177-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS Epizyme, Inc. (US) 2017-10-19 WO disclosed